Omega Therapeutics, Inc. - Common Stock
Omega Therapeutics, Inc. - Common Stock
Action · US68217N1054 · OMGA (XNAS)
Aperçu Indicateurs financiers
Pas de cours
n/a

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
- - 0,00 % 0,00 % -84,76 % -92,77 % -99,08 %

Profil de l'entreprise pour Omega Therapeutics, Inc. - Common Stock Action

Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of genes that have been strongly linked to cell-growth inhibition in patients with diabetes and other conditions to restore the capacity for corneal regeneration; to down-regulate expression of the CXCL1, 2, 3, and IL-8 gene cluster; to control expression of genes implicated in patients with idiopathic pulmonary fibrosis to halt or reverse disease progression and improve disease outcomes; to down-regulate the expression of SFRP1, a protein that inhibits hair growth; and to treat non-small cell lung cancer and small cell lung cancer. It is also developing OTX-2002 to down-regulate c-Myc, an oncogene. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Données de l'entreprise

Nom Omega Therapeutics, Inc. - Common Stock
Société Omega Therapeutics, Inc.
Symbole OMGA
Site web https://www.omegatherapeutics.com
Marché d'origine XNAS NASDAQ
ISIN US68217N1054
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Kaan Certel Ph.D.
Pays États-Unis d'Amérique
Devise USD
Employés 0,1 T
Adresse 20 Acorn Park Drive, 02140 Cambridge
Date d'introduction en bourse 2021-07-30

Symboles boursiers

Nom Symbole
NASDAQ OMGA

Autres actions

Les investisseurs qui détiennent Omega Therapeutics, Inc. - Common Stock ont également les actions suivantes dans leur portefeuille :
NOMURA BANK INTERNATIONAL PLC 15Y CR ACC NTS LKD 3M $ LIBOR 14/05/25
NOMURA BANK INTERNATIONAL PLC 15Y CR ACC NTS LKD 3M $ LIBOR 14/05/25 Obligation
ZIMMER BIOMET S 15/45
ZIMMER BIOMET S 15/45 Obligation
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025